Start Printed Page 72710
Food and Drug Administration, HHS.
The Food and Drug Administration (FDA) is announcing that a collection of information entitled “Adverse Experience Reporting for Licensed Biological Products; and General Records” has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.
Start Further Info
FOR FURTHER INFORMATION CONTACT:
Ila S. Mizrachi, Office of Information Management, Food and Drug Administration, 1350 Piccard Dr., PI50-400B, Rockville, MD 20850, (301) 796-7726, email@example.com.
End Further Info
Start Supplemental Information
On July 19, 2011, the Agency submitted a proposed collection of information entitled “Adverse Experience Reporting for Licensed Biological Products; and General Records” to OMB for review and clearance under 44 U.S.C. 3507. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. OMB has now approved the information collection and has assigned OMB control number 0910-0308. The approval expires on November 30, 2014. A copy of the supporting statement for this information collection is available on the Internet at http://www.reginfo.gov/public/do/PRAMain.
End Supplemental Information
Dated: November 18, 2011.
Acting Assistant Commissioner for Policy.
[FR Doc. 2011-30326 Filed 11-23-11; 8:45 am]
BILLING CODE 4160-01-P